Title : In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions.

Pub. Date : 2009 Jun

PMID : 19299526






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions. Thiabendazole cytochrome P450 family 1 subfamily A member 2 Homo sapiens
2 Thiabendazole (TBZ) and its major metabolite 5-hydroxythiabendazole (5OH-TBZ) were screened for potential time-dependent inhibition (TDI) against CYP1A2. Thiabendazole cytochrome P450 family 1 subfamily A member 2 Homo sapiens
3 Thiabendazole (TBZ) and its major metabolite 5-hydroxythiabendazole (5OH-TBZ) were screened for potential time-dependent inhibition (TDI) against CYP1A2. Thiabendazole cytochrome P450 family 1 subfamily A member 2 Homo sapiens
4 IC(50) shift studies also demonstrated that TBZ was a TDI of CYP1A2. Thiabendazole cytochrome P450 family 1 subfamily A member 2 Homo sapiens